Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.

MLA

Olmos, D., et al. “Treatment Patterns and Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients with and without Somatic or Germline Alterations in Homologous Recombination Repair Genes.” Annals of Oncology, vol. 35, no. 5, May 2024, pp. 458–72. EBSCOhost, https://doi.org/10.1016/j.annonc.2024.01.011.

APA

Olmos, D., Lorente, D., Alameda, D., Cattrini, C., Romero-Laorden, N., Lozano, R., Lopez-Casas, P. P., Jambrina, A., Capone, C., Vanden Broecke, A. M., Trevisan, M., Van Sanden, S., Jürgens, A., Herrera-Imbroda, B., & Castro, E. (2024). Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. Annals of Oncology, 35(5), 458–472. https://doi.org/10.1016/j.annonc.2024.01.011

Chicago

Olmos, D., D. Lorente, D. Alameda, C. Cattrini, N. Romero-Laorden, R. Lozano, P.P. Lopez-Casas, et al. 2024. “Treatment Patterns and Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients with and without Somatic or Germline Alterations in Homologous Recombination Repair Genes.” Annals of Oncology 35 (5): 458–72. doi:10.1016/j.annonc.2024.01.011.